DIVISLAB's weekly performance was lackluster, with a return of -2.29% and a Sharpe Ratio of -0.56, indicating poor risk-adjusted returns. The stock's volatility was moderate at 16.29%, which is relatively in line with its peers. Despite this, DIVISLAB outperformed its peers, with a relatively better return compared to DRREDDY, SUNPHARMA, and CIPLA. However, the stock's Max Drawdown of -2.29% suggests that it was still a relatively risky investment this week.

[Volatility: 16.29%]